1. The past time-series ILI occurrences over the 5 weeks show a fluctuating but relatively stable trend, with values of ['2064' (Week 48, 2020), '2078' (Week 49, 2020), '2222' (Week 50, 2020), '1994' (Week 51, 2020), '2028' (Week 52, 2020)]. While Week 50, 2020, exhibited a noticeable peak with 2222 occurrences, the subsequent values declined slightly, though remaining close to 2000. This pattern indicates overall stability in ILI activity despite periodic fluctuations.

2. A weak correlation is observed between the past and future ILI occurrences. Although the future value of 1805 (Week 5, 2021) reflects a decrease from the values seen in the past data (Weeks 48–52, 2020), the consistent and moderate ILI occurrences during the past 5 weeks suggest residual respiratory illness activity that aligns with the relatively high level of future occurrences.

3. Several factors from the CDC reports support the observed future ILI occurrences:
   - Outpatient visits for ILI remained consistent at 1.6% across all 5 weeks (Weeks 48–52, 2020), below the national baseline of 2.6%. This stability reflects persistent, though suppressed, ILI activity that likely contributed to the future occurrences of 1805.
   - Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) consistently exceeded epidemic thresholds during Weeks 48–52, 2020 (e.g., 12.8% in Week 48 to 13.6% in Weeks 51–52, 2020), with COVID-19 as the primary driver. This sustained PIC mortality indicates ongoing respiratory-related health impacts, indirectly influencing future ILI levels.
   - The unusually low influenza activity during Weeks 48–52, 2020, with positivity rates between 0.1% and 0.3%, indicates suppressed influenza spread. However, widespread COVID-19 and non-specific respiratory illnesses likely sustained ILI levels, contributing to the future occurrences.

4. In summary, the reported 1805 future ILI occurrences (Week 5, 2021) can be attributed to the relatively stable ILI trend over Weeks 48–52, 2020, persistent outpatient ILI visits at 1.6%, elevated but COVID-19-driven PIC mortality above epidemic thresholds, and the compounding effects of suppressed influenza circulation and pandemic-driven healthcare-seeking behavior changes.